This year’s 2021 entry is the team’s second ‘Win’ and third consecutive year being named ‘Highly Commended’ for the award.
Our submission demonstrated a powerful combination of human understanding and technological innovation. Taking the challenges of the pandemic and the evolution of new tools into consideration it delivered beyond the brief with an innovative, relevant and cost-efficient solution.
Use the form to download our full entry.
From the judges
“This was a strong all-round entry that carefully considered every aspect of the RFP and really brought the proposal to life with relevant and welcome suggestions. Realistic pricing, sound, industry-recognised recommendations and a robust testing process set this entry apart. The addition of interactive AI functionality gave the entry an interesting unique selling point, that enhanced the clear, well-presented proposal. The Judges would like to congratulate the winners on this compelling entry.”
About the competition
This year’s brief was in the area of Type 2 diabetes. A fictitious pharma company client wanted to harness the power of technology to help patients manage their condition more effectively in both a clinical and holistic sense. There was a complex sample requirement, including patients and carers, as well as a variety of healthcare professionals. Teams had to provide a detailed proposal, including costs, timelines, and compliance considerations. Learn more about this award here.